| Year |
Citation |
Score |
| 2024 |
de Sanjosé S, Perkins RB, Campos N, Inturrisi F, Egemen D, Befano B, Rodriguez AC, Jerónimo J, Cheung LC, Desai K, Han P, Novetsky AP, Ukwuani A, Marcus J, Ahmed SR, et al. Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategy. Elife. 12. PMID 38224340 DOI: 10.7554/eLife.91469 |
0.518 |
|
| 2023 |
Ahmed SR, Befano B, Lemay A, Egemen D, Rodriguez AC, Angara S, Desai K, Jeronimo J, Antani S, Campos N, Inturrisi F, Perkins R, Kreimer A, Wentzensen N, Herrero R, et al. Reproducible and clinically translatable deep neural networks for cervical screening. Scientific Reports. 13: 21772. PMID 38066031 DOI: 10.1038/s41598-023-48721-1 |
0.501 |
|
| 2023 |
Spencer JC, Burger EA, Campos NG, Regan MC, Sy S, Kim JJ. Adapting a model of cervical carcinogenesis to self-identified Black women to evaluate racial disparities in the United States. Journal of the National Cancer Institute. Monographs. 2023: 188-195. PMID 37947333 DOI: 10.1093/jncimonographs/lgad015 |
0.317 |
|
| 2023 |
de Sanjosé S, Perkins RB, Campos NG, Inturrisi F, Egemen D, Befano B, Rodriguez AC, Jerónimo J, Cheung LC, Desai K, Han P, Novetsky AP, Ukwuani A, Marcus J, Ahmed SR, et al. Design of the HPV-Automated Visual Evaluation (PAVE) Study: Validating a Novel Cervical Screening Strategy. Medrxiv : the Preprint Server For Health Sciences. PMID 37693492 DOI: 10.1101/2023.08.30.23294826 |
0.515 |
|
| 2023 |
Perkins RB, Smith DL, Jeronimo J, Campos NG, Gage JC, Hansen N, Rodriguez AC, Cheung LC, Egemen D, Befano B, Novetsky AP, Martins S, Kalpathy-Cramer J, Inturrisi F, Ahmed SR, et al. Use of risk-based cervical screening programs in resource-limited settings. Cancer Epidemiology. 84: 102369. PMID 37105017 DOI: 10.1016/j.canep.2023.102369 |
0.372 |
|
| 2023 |
Befano B, Campos NG, Egemen D, Herrero R, Schiffman M, Porras C, Lowy DR, Rodriguez AC, Schiller JT, Ocampo R, Hildesheim A, Sampson JN, Das S, Kreimer AR, Cheung LC. Estimating human papillomavirus vaccine efficacy from a single-arm trial: Proof-of-principle in the Costa Rica Vaccine Trial. Journal of the National Cancer Institute. PMID 37040086 DOI: 10.1093/jnci/djad064 |
0.401 |
|
| 2023 |
Ahmed SR, Befano B, Lemay A, Egemen D, Rodriguez AC, Angara S, Desai K, Jeronimo J, Antani S, Campos N, Inturrisi F, Perkins R, Kreimer A, Wentzensen N, Herrero R, et al. Reproducible and Clinically Translatable Deep Neural Networks for Cancer Screening. Research Square. PMID 36909463 DOI: 10.21203/rs.3.rs-2526701/v1 |
0.517 |
|
| 2023 |
Landy R, Haber G, Graubard BI, Campos NG, Sy S, Kim JJ, Burger EA, Cheung LC, Katki HA, Gillison ML, Chaturvedi AK. Upper age-limits for US male HPV-vaccination for oropharyngeal cancer prevention: A microsimulation-based modeling study. Journal of the National Cancer Institute. PMID 36655795 DOI: 10.1093/jnci/djad009 |
0.556 |
|
| 2022 |
Shastri SS, Temin S, Almonte M, Basu P, Campos NG, Gravitt PE, Gupta V, Lombe DC, Murillo R, Nakisige C, Ogilvie G, Pinder LF, Poli UR, Qiao Y, Woo YL, et al. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update. Jco Global Oncology. 8: e2200217. PMID 36162041 DOI: 10.1200/GO.22.00217 |
0.398 |
|
| 2022 |
Adebamowo SN, Befano B, Cheung LC, Rodriguez AC, Demarco M, Rydzak G, Chen X, Porras C, Herrero R, Kim JJ, Castle PE, Wentzensen N, Kreimer AR, Schiffman M, Campos NG. Different Human Papillomavirus Types Share Early Natural History Transitions in Immunocompetent Women. International Journal of Cancer. PMID 35603904 DOI: 10.1002/ijc.34128 |
0.553 |
|
| 2022 |
Barnard-Mayers R, Kouser H, Cohen JA, Tassiopoulos K, Caniglia EC, Moscicki AB, Campos NG, Caunca MR, Seage GRS, Murray EJ. A case study and proposal for publishing directed acyclic graphs: The effectiveness of the quadrivalent human papillomavirus vaccine in perinatally HIV Infected girls. Journal of Clinical Epidemiology. 144: 127-135. PMID 34998951 DOI: 10.1016/j.jclinepi.2021.12.028 |
0.43 |
|
| 2022 |
Porras C, Sampson JN, Herrero R, Gail MH, Cortés B, Hildesheim A, Cyr J, Romero B, Schiller JT, Montero C, Pinto LA, Schussler J, Coronado K, Sierra MS, Kim JJ, ... ... Campos NG, et al. Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial. Vaccine. 40: 76-88. PMID 34857420 DOI: 10.1016/j.vaccine.2021.11.041 |
0.453 |
|
| 2021 |
Desai KT, Befano B, Xue Z, Kelly H, Campos N, Egemen D, Gage J, Rodriguez AC, Sahasrabuddhe V, Levitz D, Pearlman P, Jeronimo J, Antani S, Schiffman M, de Sanjose S. The development of "Automated Visual Evaluation" for cervical cancer screening: The promise and challenges in adapting deep-learning for clinical testing. International Journal of Cancer. PMID 34800038 DOI: 10.1002/ijc.33879 |
0.455 |
|
| 2021 |
Spencer JC, Campos NG, Burger EA, Sy S, Kim JJ. Potential Effectiveness of a Therapeutic HPV Intervention Campaign in Uganda. International Journal of Cancer. PMID 34741526 DOI: 10.1002/ijc.33867 |
0.562 |
|
| 2021 |
Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ. Retraction: Impact and Cost-effectiveness of Human Papillomavirus Vaccination Campaigns. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 30: 1283. PMID 34074734 DOI: 10.1158/1055-9965.EPI-21-0455 |
0.358 |
|
| 2021 |
Campos NG, Chaturvedi AK, Kreimer AR. Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies. Journal of the National Cancer Institute. PMID 33876237 DOI: 10.1093/jnci/djab081 |
0.485 |
|
| 2021 |
Campos NG, Scarinci IC, Tucker L, Peral S, Li Y, Regan MC, Sy S, Castle PE, Kim JJ. Cost-effectiveness of offering cervical cancer screening with HPV self-sampling among African-American women in the Mississippi Delta. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33771846 DOI: 10.1158/1055-9965.EPI-20-1673 |
0.524 |
|
| 2021 |
Campos NG, Demarco M, Bruni L, Desai KT, Gage JC, Adebamowo SN, de Sanjose S, Kim JJ, Schiffman M. A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer. Preventive Medicine. 144: 106438. PMID 33678235 DOI: 10.1016/j.ypmed.2021.106438 |
0.491 |
|
| 2020 |
Scarinci IC, Li Y, Tucker L, Campos NG, Kim JJ, Peral S, Castle PE. Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial. Preventive Medicine. 106358. PMID 33338505 DOI: 10.1016/j.ypmed.2020.106358 |
0.47 |
|
| 2020 |
Paul P, Hammer A, Rositch AF, Burke AE, Viscidi RP, Silver MI, Campos N, Youk AO, Gravitt PE. Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior. The Journal of Infectious Diseases. PMID 32870982 DOI: 10.1093/Infdis/Jiaa557 |
0.577 |
|
| 2020 |
Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries. International Journal of Cancer. PMID 32706907 DOI: 10.1002/Ijc.33233 |
0.514 |
|
| 2020 |
Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W, Gage JC, Befano B, Perkins RB, He X, Dallal C, Chen J, et al. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. Eclinicalmedicine. 22: 100293. PMID 32510043 DOI: 10.1016/J.Eclinm.2020.100293 |
0.641 |
|
| 2020 |
Hammer A, Demarco M, Campos N, Befano B, Gravitt PE, Cheung L, Lorey TS, Poitras N, Kinney W, Wentzensen N, Castle PE, Schiffman M. Study of the Risks of CIN3+ detection following multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California. International Journal of Cancer. PMID 32141607 DOI: 10.1002/Ijc.32950 |
0.626 |
|
| 2019 |
Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M, Kim J. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. Preventive Medicine. 105931. PMID 31765712 DOI: 10.1016/J.Ypmed.2019.105931 |
0.648 |
|
| 2019 |
Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ. Impact and cost-effectiveness of human papillomavirus (HPV) vaccination campaigns. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31666282 DOI: 10.1158/1055-9965.Epi-19-0767 |
0.601 |
|
| 2019 |
Canfell K, Kim JJ, Kulasingam S, Berkhof J, Barnabas R, Bogaards JA, Campos N, Jennett C, Sharma M, Simms KT, Smith MA, Velentzis LS, Brisson M, Jit M. HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Research (Amsterdam, Netherlands). 100184. PMID 31505258 DOI: 10.1016/J.Pvr.2019.100184 |
0.629 |
|
| 2019 |
Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Masch R, Cremer M, Kim JJ. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 30702142 DOI: 10.1002/Ijgo.12773 |
0.662 |
|
| 2018 |
Campos NG, Tsu V, Jeronimo J, Regan C, Resch S, Clark A, Sy S, Kim JJ. Health impact of delayed implementation of cervical cancer screening programs in India: A modelling analysis. International Journal of Cancer. PMID 30132850 DOI: 10.1002/Ijc.31823 |
0.647 |
|
| 2018 |
Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M, Regan C, Sy S, Liu G, Tsu V, Jeronimo J, et al. Cost-effectiveness of cervical cancer screening in women living with HIV in South Africa: A mathematical modeling study. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29916959 DOI: 10.1097/Qai.0000000000001778 |
0.6 |
|
| 2018 |
Mezei AK, Pedersen HN, Sy S, Regan C, Mitchell-Foster SM, Byamugisha J, Sekikubo M, Armstrong H, Rawat A, Singer J, Ogilvie GS, Kim JJ, Campos NG. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial. Bmj Open. 8: e020484. PMID 29895648 DOI: 10.1136/Bmjopen-2017-020484 |
0.612 |
|
| 2018 |
Burger EA, Campos NG, Sy S, Regan C, Kim JJ. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Vaccine. PMID 29807710 DOI: 10.1016/J.Vaccine.2018.04.061 |
0.547 |
|
| 2018 |
Castle PE, Wheeler CM, Campos NG, Sy S, Burger EA, Kim JJ. Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S. Preventive Medicine. 111: 177-179. PMID 29548787 DOI: 10.1016/J.Ypmed.2018.03.011 |
0.459 |
|
| 2017 |
Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study. Bmc Cancer. 17: 791. PMID 29178896 DOI: 10.1186/S12885-017-3786-3 |
0.627 |
|
| 2017 |
Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, et al. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29150480 DOI: 10.1158/1055-9965.Epi-17-0378 |
0.432 |
|
| 2017 |
Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting. Health Policy and Planning. PMID 28973511 DOI: 10.1093/heapol/czx076 |
0.564 |
|
| 2017 |
Campos NG, Jeronimo J, Tsu V, Castle PE, Mvundura M, Kim JJ. The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28710075 DOI: 10.1158/1055-9965.Epi-16-0787 |
0.58 |
|
| 2017 |
Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ. Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings. Cancer Medicine. PMID 28707435 DOI: 10.1002/Cam4.1123 |
0.638 |
|
| 2017 |
Campos NG, Sharma M, Clark A, Lee K, Geng F, Regan C, Kim J, Resch S. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 138: 47-56. PMID 28691334 DOI: 10.1002/Ijgo.12184 |
0.639 |
|
| 2017 |
Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua. Bmj Open. 7: e015048. PMID 28619772 DOI: 10.1136/Bmjopen-2016-015048 |
0.65 |
|
| 2017 |
Kim JJ, Burger EA, Sy S, Campos NG. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus. Journal of the National Cancer Institute. 109: 1-9. PMID 28376222 DOI: 10.1093/jnci/djw216 |
0.607 |
|
| 2017 |
Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting. Health Policy and Planning. PMID 28369405 DOI: 10.1093/Heapol/Czw182 |
0.621 |
|
| 2017 |
Maza M, Alfaro K, Garai J, Velado MM, Gage JC, Castle PE, Felix J, Luciani S, Campos N, Kim J, Masch R, Cremer M. Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country. Gynecologic Oncology Reports. 20: 58-61. PMID 28337474 DOI: 10.1016/J.Gore.2017.02.011 |
0.629 |
|
| 2017 |
Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, Byamugisha JK, Kim JJ, Bryan S, Ogilvie GS. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review. International Journal of Cancer. PMID 28297074 DOI: 10.1002/Ijc.30695 |
0.631 |
|
| 2017 |
Kim JJ, Burger EA, Sy S, Campos NG. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus. Journal of the National Cancer Institute. 109. PMID 27754955 DOI: 10.1093/Jnci/Djw216 |
0.655 |
|
| 2016 |
Campos NG, Tsu V, Jeronimo J, Mvundura M, Lee K, Kim JJ. To Expand Coverage, or Increase Frequency: Quantifying the Tradeoffs between Equity and Efficiency Facing Cervical Cancer Screening Programs in Low-Resource Settings. International Journal of Cancer. PMID 27925175 DOI: 10.1002/Ijc.30551 |
0.579 |
|
| 2016 |
Campos NG, Sharma M, Clark A, Kim JJ, Resch SC. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries. Plos One. 11: e0164000. PMID 27711124 DOI: 10.1371/Journal.Pone.0164000 |
0.511 |
|
| 2015 |
Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, Hunt WC, Waxman A, Wheeler CM. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. Annals of Internal Medicine. 163: 589-97. PMID 26414147 DOI: 10.7326/M15-0420 |
0.546 |
|
| 2015 |
Seay JS, Carrasquillo O, Campos NG, McCann S, Amofah A, Pierre L, Kobetz E. Cancer Screening Utilization Among Immigrant Women in Miami, Florida. Progress in Community Health Partnerships : Research, Education, and Action. 9: 11-20. PMID 26213400 DOI: 10.1353/Cpr.2015.0029 |
0.448 |
|
| 2015 |
Campos NG, Castle PE, Wright TC, Kim JJ. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage. International Journal of Cancer. Journal International Du Cancer. PMID 25943074 DOI: 10.1002/Ijc.29594 |
0.621 |
|
| 2015 |
Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Cremer ML, Kim JJ. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. International Journal of Cancer. Journal International Du Cancer. 137: 893-902. PMID 25639903 DOI: 10.1002/Ijc.29438 |
0.666 |
|
| 2015 |
Campos NG, Tsu V, Jeronimo J, Mvundura M, Lee K, Kim JJ. When and how often to screen for cervical cancer in three low- and middle-income countries: A cost-effectiveness analysis Papillomavirus Research. 1: 38-58. DOI: 10.1016/J.Pvr.2015.05.003 |
0.508 |
|
| 2015 |
Seay JS, Carrasquillo O, Campos NG, McCann S, Amofah A, Pierre L, Kobetz E. Cancer screening utilization among immigrant women in Miami, Florida Progress in Community Health Partnerships: Research, Education, and Action. 9: 9. |
0.337 |
|
| 2014 |
Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ. An updated natural history model of cervical cancer: derivation of model parameters. American Journal of Epidemiology. 180: 545-55. PMID 25081182 DOI: 10.1093/Aje/Kwu159 |
0.616 |
|
| 2013 |
Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Vaccine. 31: F60-72. PMID 24331749 DOI: 10.1016/J.Vaccine.2012.07.093 |
0.609 |
|
| 2012 |
Kiatpongsan S, Campos NG, Kim JJ. Potential Benefits of Second-Generation Human Papillomavirus Vaccines Plos One. 7. PMID 23144879 DOI: 10.1371/Journal.Pone.0048426 |
0.611 |
|
| 2012 |
Kobetz E, Kish JK, Campos NG, Koru-Sengul T, Bishop I, Lipshultz H, Barton B, Barbee L. Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action. Journal of Oncology. 2012: 728397. PMID 22619675 DOI: 10.1155/2012/728397 |
0.618 |
|
| 2012 |
Campos NG, Kim JJ, Castle PE, Ortendahl JD, O'Shea M, Diaz M, Goldie SJ. Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. International Journal of Cancer. Journal International Du Cancer. 130: 2672-84. PMID 21717458 DOI: 10.1002/Ijc.26269 |
0.717 |
|
| 2011 |
Campos NG, Rodriguez AC, Castle PE, Herrero R, Hildesheim A, Katki H, Kim JJ, Wacholder S, Morales J, Burk RD, Schiffman M. Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study. The Journal of Infectious Diseases. 203: 823-7. PMID 21257737 DOI: 10.1093/Infdis/Jiq131 |
0.524 |
|
| 2008 |
Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine. 26: 4080-93. PMID 18550229 DOI: 10.1016/J.Vaccine.2008.04.053 |
0.674 |
|
| 2007 |
Campos NG, Salomon JA, Servoss JC, Nunes DP, Samet JH, Freedberg KA, Goldie SJ. Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV. The American Journal of Medicine. 120: 272-9. PMID 17349451 DOI: 10.1016/J.Amjmed.2006.06.036 |
0.499 |
|
| 2006 |
Campos NG, Goldie SJ. HPV Genotypes in Women with HIV Nejm Journal Watch. 2006. DOI: 10.1056/Ac200608280000003 |
0.635 |
|
| Show low-probability matches. |